Pharmacological Inhibition of Protein Lipidation.
Lipid modifications of mammalian proteins are widespread, modifying thousands of targets involved in all aspects of cellular physiology cellular physiology. Broadly, lipidations serve to increase protein hydrophobicity and association with cellular membranes. Often, these modifications are absolutely essential for protein stability and localization, and serve critical roles in dynamic regulation of protein function. A number of lipidated proteins are associated with diseases, including parasite infections, neurological diseases, diabetes, and cancer, suggesting that lipid modifications represent potentially attractive targets for pharmacological intervention. This review briefly describes the various types of posttranslational protein lipid modifications, proteins modified by them, and the enzymatic machinery associated with these. We then discuss several case studies demonstrating successful development of lipidation inhibitors of potential (and more rarely, realized) clinical value. Although this field remains in its infancy, we believe these examples demonstrate the potential utility of targeting protein lipidation as a viable strategy for inhibiting the function of pathogenic proteins.
University of Texas Medical School, Houston, TX, USA.
Lakshmi
L
Ganesan
University of Texas Medical School, Houston, TX, USA. ilya.levental@uth.tmc.edu.
Ilya
I
Levental
D000818:Animals; D055808:Drug Discovery; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects*; D008055:Lipids / Q000737:chemistry; D058990:Molecular Targeted Therapy; D011499:Protein Processing, Post-Translational / Q000187:drug effects*; D011506:Proteins / Q000737:chemistry / Q000378:metabolism*
D008055:Lipids; D011506:Proteins
Lipid raft; Membrane binding; Microdomain; Post-translational modification; Protein lipidation; Subcellular localization